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A 27-year-old woman presented with generalized dystonia that be-
gan at age 15 years as dystonic posturing of the right hand when writ-
ing. She was diagnosed with cervical dystonia and botulinum toxin
injections were tried, providing
minimal pain relief and no im-
provement of the dystonia. The
cervical dystonia was partially
responsive to sensory tricks (Video, A). She was most bothered by
her cervical dystonia, and disability was 6 on Part II of the Toronto
Western Spasmodic Torticollis Rating Scale (TWSTRS).
On examination, she had increased rate of eye blinking and oc-
casional spasms involving the lower face, mouth, and jaw, and mild
dysarthria. Severe right torticollis and an intermittent head tremor
were present. Dystonic posturing of the right upper extremity and
increased handgrip were observed while writing. Mild left foot in-
version was present while walking. The Fahn-Marsden Scale score
was 16, and TWSTRS Part I score was 20. A trial of carbidopa/
levodopa did not provide benefit.
Deep brain stimulation (DBS) surgery targeting the globus palli-
dus internus (GPi) was performed, resulting in moderate improvement
1monthaftertheprocedure,priortoinitialprogramming(TWSTRSPart
I = 18, Fahn-Marsden = 8.5) (Video, B). She experienced further ben-
efit2monthsafter initialprogramming(TWSTRSPartI = 13,Fahn-Mars-
den = 3). Whole-exome sequencing revealed a frameshift mutation,
confirmed as a novel 2–base pair deletion mutation in exon 3 of the
THAP1 gene (heterozygous exon 3 c.377_378delCT, p.Pro126Args*2)
via full sequencing analysis of DYT6.
Discussion
DYT6 dystonia is an autosomal dominant form of isolated dysto-
nia, presenting in adolescence or adulthood.1 Symptoms are vari-
able, commonly affecting the cranio-cervical region.1 The locus has
been identified on chromosome 8p21-q22 and the gene is desig-
nated THAP1 (Thanatos-associated protein 1).2
Deep brain stimulation of the GPi in patients with primary gener-
alized or segmental dystonia can result in significant improvement dur-
ing long-term follow-up. Patients with DYT6 dystonia generally have
a relatively modest response, but response varies with percentages of
improvement of dystonia rating scale scores from 16% to 55%.3
Jech et al4 reported a patient with generalized dystonia and a
THAP1 mutation located on exon 2, who had an excellent response
to GPi DBS. Our case is another example of a novel THAP1 mutation
expressed as a phenotype that responded well. Different muta-
tions may not only have different clinical presentations, but also vari-
able response patterns to DBS. Sorting this out may help with
preoperative decisions.
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